News Center

Home page

Peak Report

News reports

The company held the second session of the 11th board of directors and the second session of the 10th board of supervisors to examine and approve the annual work report and other relevant proposals.

Release time:

2021-05-06

News from our newspaper # February 24 , Chairman Jiang Xiaomeng of the Group Company presided over the meeting of the 11th Board of Directors of the Company, deliberating and passing 2020 Annual Board of Directors Report, 2020 General Manager Business Report, 2020 Annual Report and other 15 related reports and proposals. The 10th 2 Supervisory Board of the Company was also held on the same day.

Due to the new coronary pneumonia epidemic, the national cement industry was greatly affected in the short term, but the overall operation of the industry was stable throughout the year. 2020 , the company made new progress in the construction of cement projects. The off-site technological transformation project (with waste heat power generation) of the new dry cement production line with a daily output of 4500 tons of clinker in Huangping, Guizhou was completed and put into trial production in 9 . The production license was successfully obtained during the year. All production and operation indexes of the production line basically reached the expected targets. The cement enterprises under the company actively carry out benchmarking management and standardized management, continuously promote the "three reductions and three improvements" activities, steadily implement various technological transformation work, and continuously improve the production efficiency of enterprises while strictly controlling production costs. A total of ,526 tons of cement and clinker were sold throughout the year. Daye Peak has implemented more than 10 technical reforms such as the technical reform of the newly added raw meal online analyzer, the technical reform of the grate cooler, the transformation of the cement mill system, and the transformation of the waste heat power generation DCS . The quality of raw meal has been significantly improved and the standard coal consumption per ton of clinker has decreased. Yunnan Peak has completed the technical renovation of grate cooler, preheater and other equipment, effectively increasing the output of rotary kiln. In addition, the company integrated part of the equity participation in the cement business and sold the equity of Guangxi Huying; participated in the major asset reorganization of Tianshan shares with the equity of Southern Cement held by the company, further optimizing the asset allocation structure.

2020

, the reform of the pharmaceutical industry continued to increase, the industry pattern further changed. Jianfeng Pharmaceutical and its subsidiaries further strengthened product research and development and innovation. Paroxetine Hydrochloride Tablets passed the consistency evaluation and obtained the production approval documents of esomeprazole sodium raw materials and injections. Subsidiaries Jianfeng Yien and Zhejiang Erying respectively obtained the clinical approval documents of Class I anti-tumor new drug JFAN-1001 and Class III new drug acetaminophen suppository. Jianfeng Pharmaceutical and its subsidiaries have made progress in a number of technological transformation and engineering construction. The annual output of 20 .6 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical has been included in the key technological transformation project of Jinhua City in 2020 . At present, the civil work of the main project has been basically completed, and equipment installation and debugging, quality system introduction and verification are underway. New North Card and New Peak North Card have fully implemented technical transformation, on the basis of its existing pesticides and pharmaceutical intermediates, it will be upgraded to become a comprehensive R & D and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of APIs and preparations of Jianfeng Pharmaceutical. Peak Pharmaceutical is also actively exploring new marketing models, further improving the commission-based marketing model and incentive assessment system.

In addition, under continued market regulation, the image of the health care industry and consumer trust have recovered, and under the influence of the new crown epidemic, national health care awareness has been growing and demand for health care products has gradually recovered. Subsidiaries Jianfeng Health, Tianjin Jianfeng Natural Products and Tianjin Flanders have all passed the national high-tech enterprise certification; Jianfeng Health has newly added health food registration approval documents, realizing the customized sales and product development of multiple functional foods; Tianjin Jianfeng Natural Products has updated and optimized the product technology, effectively reducing the production cost; tianjin Flanders has obtained production licenses for special dietary foods (nutritional supplements for pregnant women and lactating mothers) and convenience foods (instant cereals), realizing product transformation. Jianfeng International Trade readjusted the layout of the warehouse base, completed the construction of two new logistics warehouses, further improved the land utilization rate and increased the operation and storage area, and made full use of the storage and transportation advantages of Jinhua South Station to effectively improve the storage and operation capacity. Peak cable through the adjustment of product structure, pay attention to the maintenance and training of large customers, the annual production and sales, profits have increased year-on-year. On the day of

, the company also held the

2 meeting of the 10th board of supervisors, deliberating and approving 5 related reports and proposals such as the company's 2020 annual board of supervisors report, 2020 annual financial final accounts report, 2020 annual profit distribution plan, etc. (residual fruit)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页